| Tag | Content |
|---|
EnhancerAtlas ID | HS131-00076 |
Organism | Homo sapiens |
Tissue/cell | ME-1 |
Coordinate | chr1:9689570-9690360 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| SPI1 | MA0080.4 | chr1:9689922-9689936 | CACTTCCTGTTTTT | - | 6.36 |
|
| | Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
| SE_09834 | chr1:9689176-9691191 | CD14 | | SE_11127 | chr1:9685398-9692209 | CD20 | | SE_17476 | chr1:9686526-9691936 | CD4p_CD25-_CD45RAp_Naive | | SE_18450 | chr1:9686607-9691837 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_22609 | chr1:9688253-9692028 | CD8_primiary | | SE_61808 | chr1:9685649-9718143 | Toledo | | SE_62727 | chr1:9686025-9718623 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I009625 | chr1 | 9685804 | 9691858 |
|
Enhancer Sequence | AATAGAAATC AAAGCCTGAG AAAGAATCGA GGAGCCACGA CCCTGCCGTG GGAAAGGCTG 60
TGTGACCTTG GCCAGGTCAC TTCACTTCTC TGAGCGCACT TGCCTGTCTG TAAAATGGGG 120
TCATGGTCTC AACCTTGGGG AGCTGCTGGG AGAAGGTGAG CTAAGATGTC AGAGGCAGGG 180
TGCAGGTGTG AAGTTCGGTC TAAAACAAAG CCCCTCGCCA CAGGGTACTC GCCGGACTCC 240
CAGCTCGCCC TAAGGCTCCC CCACCCCTGC AGTCGGGCCG GGACCGCCCC TGAGCACTTC 300
CCCGTAAGGC TGCGGTGCAC GGGCTGGGGA GCACTTCTGC ACCCTCGCTC TCCACTTCCT 360
GTTTTTCTCC CCAACGAATT TTGCGCCATT ACTCTTTCAT GGGGTGAGGG GGGAGTGGGG 420
GCGGAGGCGG AGGCCTGCCT GGGAAGGAAG CCCGGGGGTC AGAGGCGCCC AGGACACCAC 480
GAGGTTGGGA GAGGAGTGTG CTTTGCACTC TGCACTCTCC AGCTCAGAGT AGCTGAGGAT 540
GCTAGGGAGA CTGGGGGCTG GCCCACGGGG GGAGCAGAGG AGTCCTCAGT GCGGTCCTCA 600
CTCTGAAAAC AGCATTTTTC CCTAGGCTTG AGAATGCCTC CGGGATTGGA CTGATCCAGG 660
CTGGACCCAC GTCTGTCTGG TGATACCAGG GGCAGAGGGA CCACTCTGAC AGGTGAGTCT 720
AGCCTCCCTA CCCCCCGGAG GCCGTCAGGC CTTGGATCAT GGACTGCAGG GTCACTCGGT 780
GTCAGGCCCC 790
|
